Timeline of HIV/AIDS Epidemic (Source: Kaiser Family Foundation, unless otherwise noted)

Size: px
Start display at page:

Download "Timeline of HIV/AIDS Epidemic (Source: Kaiser Family Foundation, unless otherwise noted)"

Transcription

1 Timeline of HIV/AIDS Epidemic (Source: Kaiser Family Foundation, unless otherwise noted) 1980: A Los Angeles doctor examined a young man with a severe yeast infection in his throat. A count of the T4-Helper cells in the man's immune system revealed there were none. 1981: A baby in New York City who was given a series of blood transfusions, sickened quickly and died. Report from the U.S. Centers for Disease Control and Prevention (CDC) stated that from Oct 1980-May 1981: Five young, previously healthy homosexual men in Southern California were treated for pneumocystis carinii pneumonia (PCP), a protozoan-produced condition that occurs almost exclusively in persons with severely suppressed or defective immune systems. Federal officials noted that rarely prescribed drugs (Bactrim and Septra) for the treatment of PCP were being dispensed more often. (Morbidity and Mortality Weekly Report (MMWR) 1-2) Reports from New York City and San Francisco stated that from : Twenty six young to middle aged homosexual men had been diagnosed with Kaposi's sarcoma (KS), a rare cancer in this country occurring primarily in elderly men and immunosuppressed transplant recipients. (MMWR, 2-4) The first heterosexual immunosuppressed patients, including the first woman, were reported by the CDC. (MMWR, 5) 1982: Some researchers designated this new disease with the acronym GRID (Gay Related Immune Deficiency) despite the fact that the CDC reported there were known cases of heterosexual transmission. Doctors concluded that a hemophiliac patient who died of PCP became immune suppressed because of infection derived from Factor VIII, the clotting factor. Hemophiliacs were identified as a "high risk group." CDC adopted AIDS (Acquired Immune Deficiency Syndrome) as the official name of the new disease.

2 Gay Men s Health Crisis, the first community-based AIDS service provider in the U.S., established in New York City. 1983: A Public Health Service interagency report indicated that homosexual men with multiple sexual partners, users of intravenous drugs, Haitians who had recently immigrated to the U.S. and hemophiliacs were at increased risk of getting AIDS. It also stated that unexplained immune deficiency and opportunistic infections were being seen in the female sexual partners of bisexual men and of men who used intravenous drugs. Children born to these women were also experiencing serious immune related illness. This report hypothesized for the first time that the cases shared exposure to an unknown transmissible agent (perhaps similar to that of hepatitis B infection), a sexually transmitted and blood-borne microbe. Following birth of a baby girl with HIV infection, the CDC confirmed that perinatal HIV transmission was possible from infected mother to child. 1984: Thirty cases of AIDS were confirmed as having been caused by HIV infected blood transfusions. Dr. Robert Gallo of the United States identifies HIV as the cause of AIDS. CDC states that abstention from intravenous drug use and reduction of needle-sharing should also be effective in prevention transmission of the virus. Blood testing procedures were developed for the detection of HIV antibodies. The first HIV infection was detected in Thailand which eventually would have one of the world's worst infection rates attributable to its thriving international sex industry. 1985: The American Red Cross acknowledged that about one in 500 blood donors is infected with HIV, suggesting there could be thousands of people who received HIV infected blood. In the US, all donated blood began to be screened for antibodies to the virus. Two laboratory procedures, the ELISA (Enzyme-Linked Immunosorbent Assay) Test and the Western Blot Test, began to be used to detect HIV antibodies.

3 Another new retrovirus causing AIDS-like symptoms was isolated. It was called HIV-2 and was found specifically in West Africa. HIV-2 is similar in structure to HIV, the agent thought to cause most of the AIDS cases in Central Africa and other regions of the world. Cases thought to be caused by HIV-2 had a substantially lower risk of developing lethal symptoms of AIDS. First International AIDS Conference held in Atlanta. Hosted by U.S. Department of Health and Human Services (DHHS) and the World Health Organization (WHO). 1986: Ryan White, a 13 year old hemophiliac with AIDS who had been barred from attending school since September 1985, was allowed to return to classes. Opposition to his attendance slowly ended. Data suggested that the human response to the virus was broader than previously thought. Stages of HIV disease are identified: viral infection without clinical symptoms (HIV+ asymptomatic), some AIDS-related symptoms (HIV+ symptomatic), and diagnosis of one or more life-threatening, opportunistic infections such as KS or PCP, resulting in a clinical diagnosis of AIDS (Diagnosed AIDS). New studies showed that in adults, a clinical diagnosis of AIDS usually occurred more than two years after the initial infection and could develop more than five years later. 1987: The United Church Board for Homeland Ministries (UCBHM), the UCC Office for Church in Society (OCIS) and the UCC Council for Health and Human Service Ministries (CHHSM) collaborated with one another to form UCAN, a loosely formed network within the UCC. Azidothymidine (AZT), trade-named "Retrovir," was approved by the Federal Drug Administration despite limited evidence of its safety and efficacy. Its manufacturer, Burroughs Wellcome, set the price at $10, per year, making AZT the most expensive drug in history and the only drug approved for treatment of AIDS. By Executive Order, President Ronald Reagan established the Presidential Commission on the Human Immunodeficiency Virus Epidemic and named to it 13 individuals who, by their own admission, knew nothing about AIDS. A year later, they presented the President with a report containing nearly 600 recommendations. The Names Project AIDS Memorial Quilt, comprised of 1,900 panels, each memorializing a person who died from AIDS, was displayed for the first time on the mall in Washington, DC.

4 U.S. FDA adds HIV prevention as a new indication for male condoms. 1988: A rise in drug-resistant tuberculosis among AIDS patients was reported for the first time. The U.S. Surgeon General's Report on AIDS was sent to every American household. The World Health Organization estimated 5 to 10 million people worldwide had HIV infection. Nearly 1100 cases of pediatric AIDS (AIDS diagnosis in children under 13 years of age) had been reported in the U.S. Intravenous drug use in the U.S. was identified as the major cause of HIV transmission among heterosexual women and men and of perinatal HIV transmission as well. The National Academy of Sciences and the Institute of Medicine estimated that the direct annual cost of caring for AIDS patients would rise to more than $10 billion by Congress adopted legislation creating the National Commission on Acquired Immune Deficiency Syndrome, comprised of 15 members -- 5 appointed by the President (three were administration officials who were non-voting members), 5 each appointed by the leadership of the U.S. House of Representatives and the U.S. Senate. The Commission's life was extended until September 1993, at which time it issued a final report, supplementing interim reports it had issued on a variety of topics. It made a cumulative total of 30 comprehensive recommendations. 1989: In January 1989, the United Church Board for Homeland Ministries (UCBHM), the UCC Office for Church in Society (OCIS) and the UCC Council for Health and Human Service Ministries (CHHSM) co-sponsored a UCC AIDS Ministry Consultation attended by 33 UCC clergy and lay members with extensive, firsthand experience in HIV and AIDS ministry. The group included persons with HIV and AIDS, family members, pastors, counselors, AIDS service providers, educators and chaplains with rural, suburban and urban perspectives. The Consultation was initiated under the inspired leadership of the Rev. Dr. William R. "Bill" Johnson, UCBHM Secretary for AIDS Programs and Ministries Coordination. A Consultation report entitled, AIDS, Where We Live, set forth the Consultation's recommendations to the whole church and was sent to UCC Executives and Conference Ministers. One thousand copies of the report were also distributed at the UCC's 17th General Synod meeting in Fort Worth, Texas (June 1989).

5 The other important outcome from the Consultation was the creation of the United Church of Christ AIDS/HIV Network (UCAN), which participants in the Consultation had covenanted together to do. An Ad Hoc Leadership Team was formed whose primary task was to review the report of the Consultation and oversee UCAN preparations for GS17, including preparation of two General Synod resolutions called for by the Consultation. The CDC reported that although the number of new AIDS cases continued to rise, the rate of increase had slowed. The new finding was attributed to the effectiveness of AZT in delaying the onset of opportunistic infections that resulted in an AIDS diagnosis. AZT was approved for use by children with AIDS. 1990: Ryan White died of AIDS. His death spurred a U.S. Congressional movement to provide increased funds to cities hardest hit by AIDS through the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act. In the first year, it is funded at $220.5 million. Among teenagers who applied for military service between 1985 and 1989, three out of every 10,000 tested positive for HIV. Among African-American teens, the infection rate was one in 1,000. U.S. House of Representatives passes the Americans With Disabilities Act to protect the civil liberties of persons with disabilities, including people living with HIV/AIDS. David Acer, a dentist who infected several of his patients with HIV, died of AIDS. Over several years, this aberrant case provokes irrational demands for widespread HIV antibody testing of health-care workers. 1991: The CDC reported that more than 20% of persons reported with AIDS were in their 20s, suggesting that, given a period of 10 years or more between infection and the onset of symptoms, the majority of these people were probably infected with HIV during their teenage years. The CDC announced revision of its definition of AIDS, effective January 1, The new definition allowed doctors to make an AIDS diagnosis for any HIV+ person whose T-cell level dropped to 200 or fewer T-cells per cubic millimeter of blood. The Federal Drug Administration approved a second anti-aids drug, Dideoxyinosine (DDI).

6 Professional basketball superstar, Magic Johnson, announces that he is HIV-positive. The World Health Organization announces that 60% of the world's estimated AIDS cases are in Africa, which has 12% of the world's population. According to WHO, there are 92,457 AIDS cases in Africa and an estimated 7 million Africans are infected with HIV. Up to 10 million African children could be orphaned by AIDS by the year : Wisconsin Pharmacal Co. sought approval from the U.S. Food and Drug Administration to market a condom for females. The pouch-shaped, 7 inch long device made of lubricated polyurethane contains two flexible rings, one of which fits inside the vagina like a diaphragm, anchoring the sheath, while the other remains outside the body. A third anti-aids drug, Dideoxycytidine (DDC), was approved by the FDA for use against AIDS in combination with AZT. AIDS becomes number one cause of death for U.S. men ages FDA licenses first rapid HIV test, which provides results in as little as ten minutes. 1993: Affirming Persons, Saving Lives (APSL) was created, a groundbreaking curriculum for AIDS awareness and prevention education. In that same year, UCAN received the National AIDS Interfaith Network's Special Award for Outstanding Curriculum Development for APSL. At the Ninth International Conference on AIDS, held in Berlin, Dr. Michael H. Merson, director of the World Health Organization AIDS Programme, announced 14 million people are infected with HIV. President Clinton signs HIV immigration exclusion policy into law. The Social Security Administration issued new guidelines regarding disability benefits for persons living with HIV infection. The new regulations contained an updated listing of HIV-related illnesses, including those unique to HIV infected women and children, and new procedures to ensure presumptive disability payments for persons living with HIV infection. President Clinton establishes White House Office of National AIDS Policy (ONAP). 1994: AIDS becomes leading cause of death for all Americans ages 24 to 44; remains so through 1995.

7 U.S. FDA approves an oral HIV test, the first non-blood based antibody test for HIV. 1995: President Clinton establishes Presidential Advisory Council on HIV/AIDS (PACHA). First protease inhibitor, saquinavir, approved in record time by the U.S. FDA, ushering in new era of highly active antiretroviral therapy (HAART). First National HIV Testing Day created by the National Association of People with AIDS. 1996: Joint United Nations Programme on HIV/AIDS (UNAIDS) begins operations; established to advocate for global action on the epidemic, and to coordinate HIV/AIDS efforts across the UN system. The number of new AIDS cases diagnosed in the U.S. declines for first time in history of epidemic, though experience varies by sex, race and ethnicity. U.S. Congress reauthorized the Ryan White CARE Act. HIV no longer leading cause of death for all Americans ages 25-44; remains leading cause of death for African Americans in this age group. 1997: AIDS-related deaths in the U.S. decline by more than 40 percent compared to the prior year, largely due to HAART. 1998: Minority AIDS Initiative created in U.S., after African American leaders declare a state of emergency and Congressional Black Caucus (CBC) calls on the Department of Health and Human Services to do the same. U.S. Department of Health and Human Services Secretary Shalala determines that needle exchange programs are effective and do not encourage the use of illegal drugs, but Clinton Administration does not lift the ban on use of federal funds for such purposes. First large scale human trials (Phase III) for an HIV vaccine begin. 2000: U.S. Congress reauthorized the Ryan White CARE Act for the second time.

8 U.S. CDC reports that, among men who have sex with men in the U.S., African American and Latino cases exceed those among whites. 2001: At General Synod 23 (Kansas City, MO), a resolution entitled, "The Epidemic of Acquired Immune Deficiency Syndrome on the Continent of Africa," was passed. This resolution recommended information-sharing with local churches, Associations, and Conferences on how the United Church of Christ is responding to the AIDS crisis in Africa and how these groups may further assist this response. It also encouraged advocacy and support for those affected by HIV and AIDS in Africa, and called for meaningful and prayerful dialogue concerning HIV and AIDS with our partner churches on the African continent. United Nations General Assembly convenes first ever special session on AIDS, UNGASS June 5 marks 20 years since first AIDS case reported. Newly appointed U.S. Secretary of State, Colin Powell, reaffirms U.S. statement that HIV/AIDS is a national security threat. 2002: HIV is leading cause of death worldwide, among those aged Approval of OraQuick Rapid HIV-1 Antibody Test, by U.S. FDA; first rapid test to use finger prick. OraQuick granted a Clinical Laboratory Improvement Amendments (CLIA) waiver in 2003, enabling the test to be performed outside of the laboratory, allowing more widespread use. 2003: President Bush announces PEPFAR, the President s Emergency Plan for AIDS Relief, during the State of the Union Address; PEPFAR is a five-year, $15 billion initiative to address HIV/AIDS, tuberculosis, and malaria primarily in hard hit countries. 3 by 5 Initiative announced by World Health Organization, to bring treatment to 3 million people by : Leaders of the Group of Eight (G8) nations call for creation of Global HIV Vaccine Enterprise, a consortium of government and private sector groups designed to coordinate and accelerate research efforts to find an effective HIV vaccine.

9 OraQuick Rapid HIV-1 Antibody Test approved for use with oral fluid by U.S. FDA. Oral fluid rapid test is granted a CLIA waiver. 2005: UCAN recommitted itself to promote awareness and offer technical assistance to racial/ethnic minority constituencies throughout the country, who are now among the highest risk group for HIV transmission. 2006: June 5 marks a quarter century since first AIDS case reported. U.S. Congress reauthorizes the Ryan White CARE Act for the third time. U.S. Centers for Disease Control and Prevention releases revised HIV testing recommendations for health-care settings, recommending routine HIV screening for all adults, aged 13-64, and yearly screening for those at high risk. 2007: President Bush calls on Congress to reauthorize PEPFAR at $30 billion over 5 years (White House Press Release) In order to continue to increase UCAN s capacity in the most effective ways, the Wider Church Ministries Board of Directors approved a proposal to create a new 501(c)(3) for UCAN. 2008: UCAN Inc. acquired its own IRS 501(c)(3) status, in order to more effectively and efficiently carry out its mission, yet also maintain strong service ties to UCC's global community. In June 2008, UCAN demonstrated their commitment to the use of culturally/linguistically appropriate resources by publishing a Spanish language version of their HIV education cards, "Why Use Condoms". 2009: At the 27th General Synod, a Resolution Calling for Comprehensive HIV Prevention in Church and Society was overwhelmingly passed. President Obama signed the Ryan White HIV/AIDS Treatment Extension Act of 2009, which is the fourth reauthorization of the Ryan White CARE Act.

10 President Obama also announced that he would be lifting the ban which prohibits HIVpositive people from entering the United States without a waiver. The policy change took effect January 4, 2010.

The HIV Timeline:

The HIV Timeline: The HIV Timeline: 1980-2001 1918-19 Winter 1945-55 1978 1980 1981 Early Fall Nov. 1982 Mar. 1983 Early Summer 1984 Early Apr. 550,000 Americans died of influenza 'A'; 25 million deaths worldwide. Polio

More information

HIV/AIDS. The Essential Facts

HIV/AIDS. The Essential Facts HIV/AIDS The Essential Facts Educating the Church About HIV/AIDS Over the past decade, limited attention has been paid to the human immunodeficiency virus (HIV) epidemic in the United States. New England

More information

Thirty years of AIDS: A timeline of the epidemic 8 June 2011, By Lisa Cisneros

Thirty years of AIDS: A timeline of the epidemic 8 June 2011, By Lisa Cisneros Thirty years of AIDS: A timeline of the epidemic 8 June 2011, By Lisa Cisneros 1982 • The CDC establishes the term Acquired Immune Deficiency Syndrome (AIDS). • The City and County of San Francisco,

More information

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006 Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic

More information

HIV Transmission HASPI Medical Biology Lab 20

HIV Transmission HASPI Medical Biology Lab 20 HIV Transmission HASPI Medical Biology Lab 20 Background History of HIV/AIDS Acquired Immune Deficiency Syndrome (AIDS) was first seen in 1981 when large numbers of people with two rare diseases surfaced:

More information

CALLING FOR COMPREHENSIVE HIV PREVENTION IN CHURCH AND COMMUNITY

CALLING FOR COMPREHENSIVE HIV PREVENTION IN CHURCH AND COMMUNITY CALLING FOR COMPREHENSIVE HIV PREVENTION IN CHURCH AND COMMUNITY (27 th General Synod of the United Church of Christ, Grand Rapids, MI, June 29, 2009) Background Statement: Summary HIV stands for human

More information

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 S T A T E M E N T 2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 World leaders commit to reach three goals and 20 new Fast-Track Targets

More information

MMWR Analysis Provides New Details on HIV Incidence in U.S. Populations

MMWR Analysis Provides New Details on HIV Incidence in U.S. Populations MMWR Analysis Provides New Details on HIV Incidence in U.S. Populations CDC HIV/AIDS Fa c t s S e p t e m b e r 2008 On August 6, 2008, the Centers for Disease Control and Prevention (CDC) released a new

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

AUGUST 200 JULY Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act:

AUGUST 200 JULY Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act: Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act: JULY 2008 AUGUST 200 A Side-by-Side Comparison to Current Law Reauthorization of PEPFAR, The United

More information

IFMSA Policy Statement Ending AIDS by 2030

IFMSA Policy Statement Ending AIDS by 2030 IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

Renewing Momentum in the fight against HIV/AIDS

Renewing Momentum in the fight against HIV/AIDS 2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly

More information

The U.S. President s Emergency Plan for AIDS Relief (PEPFAR)

The U.S. President s Emergency Plan for AIDS Relief (PEPFAR) The U.S. President s Emergency Plan for AIDS Relief (PEPFAR) Although the U.S. has been involved in efforts to address the global AIDS crisis since the mid-1980s, the creation of the President s Emergency

More information

REPORT OF THE EXECUTIVEDIRECTOR

REPORT OF THE EXECUTIVEDIRECTOR REPORT OF THE EXECUTIVEDIRECTOR Rev. Mike Schuenemeyer Annual Meeting UCAN, Inc. March 15, 2014 UCAN, INC. United Church of Christ HIV & AIDS Network Was founded in 1988 Has been the primary vehical for

More information

Global and National trends of HIV/AIDS

Global and National trends of HIV/AIDS Research and Review Insights Research Article ISSN: 2515-2637 Global and National trends of HIV/AIDS Hikmat Bahadur Raya* Lecturer, Department of Population Studies, Tribhuvan University, Terhathum M.

More information

ACT UP (AIDS Coalition To Unleash Power): HIV/AIDS activist group founded in 1987 in New York City.

ACT UP (AIDS Coalition To Unleash Power): HIV/AIDS activist group founded in 1987 in New York City. GLOSSARY OF TERMS ACT UP (AIDS Coalition To Unleash Power): HIV/AIDS activist group founded in 1987 in New York City. Agitprop: a term used to describe political art meant to agitate and spread propaganda.

More information

HIV-AIDS IN PALM BEACH COUNTY, FLORIDA By Liz Morrison

HIV-AIDS IN PALM BEACH COUNTY, FLORIDA By Liz Morrison HIV-AIDS IN PALM BEACH COUNTY, FLORIDA By Liz Morrison Liz Morrison is the coordinator of social studies for the Parkway School District located in west St. Louis County. In 2001, Liz was selected as the

More information

The Struggle with Infectious Disease. Lecture 6

The Struggle with Infectious Disease. Lecture 6 The Struggle with Infectious Disease Lecture 6 HIV/AIDS It is generally believed that: Human Immunodeficiency Virus --------- causes ------------- Acquired Immunodeficiency Syndrome History of HIV HIV

More information

Manitoba Health Statistical Update on HIV/AIDS

Manitoba Health Statistical Update on HIV/AIDS Manitoba Health Statistical Update on HIV/AIDS 1985 - Dec 2001 Communicable Disease Control Unit Public Health Branch MANITOBA HEALTH STATISTICAL UPDATE ON HIV/AIDS 1985 TO DECEMBER 2001 HIV January 1,

More information

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier

More information

Immunodeficiencies HIV/AIDS

Immunodeficiencies HIV/AIDS Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement

More information

LISTEN, LEARN, LIVE!

LISTEN, LEARN, LIVE! LISTEN, LEARN, LIVE! World AIDS Campaign with Children and Young People Facts and Figures Education International International Federation of Red Cross and Red Crescent Societies International Save the

More information

Partnerships between UNAIDS and the Faith-Based Community

Partnerships between UNAIDS and the Faith-Based Community Partnerships between UNAIDS and the Faith-Based Community Sally Smith- Partnership Adviser. Micah Network: Global Consultation-Churches Living with HIV Pattaya Thailand October 2008 UNAIDS Summary of 2008

More information

HIV/AIDS EPIDEMIOLOGY. Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014

HIV/AIDS EPIDEMIOLOGY. Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014 HIV/AIDS EPIDEMIOLOGY Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014 HOUSEKEEPING ANNOUNCEMENTS AUDIO Can you hear us? You will be accessing

More information

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director. 30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

More information

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s

More information

Preface: Evolving Ethical Issues Over the Course of the AIDS Pandemic

Preface: Evolving Ethical Issues Over the Course of the AIDS Pandemic 1 Public Health Reviews, Vol. 34, No 1 Preface: Evolving Ethical Issues Over the Course of the AIDS Pandemic Anthony S. Fauci, MD 1 ABSTRACT In the early years of the AIDS pandemic, one of the major ethical

More information

1.2 Building on the global momentum

1.2 Building on the global momentum 1.1 Context HIV/AIDS is an unprecedented global development challenge, and one that has already caused too much hardship, illness and death. To date, the epidemic has claimed the lives of 20 million people,

More information

The Faith in Prevention Training Manual: Tools for Your HIV/AIDS Ministry A faith-based model of partnership to stop HIV

The Faith in Prevention Training Manual: Tools for Your HIV/AIDS Ministry A faith-based model of partnership to stop HIV The Faith in Prevention Training Manual: Tools for Your HIV/AIDS Ministry A faith-based model of partnership to stop HIV My people perish for lack of knowledge Hosea 4:6a Developed By Starr Smith Adler

More information

HIV/AIDS HIV HUMAN IMMUNODEFICIENCY VIRUS INFECTION AIDS ACQUIRED IMMUNE DEFICIENCY SYNDROME

HIV/AIDS HIV HUMAN IMMUNODEFICIENCY VIRUS INFECTION AIDS ACQUIRED IMMUNE DEFICIENCY SYNDROME SESSION SIX HIV/AIDS HIV/AIDS HIV HUMAN IMMUNODEFICIENCY VIRUS INFECTION AIDS ACQUIRED IMMUNE DEFICIENCY SYNDROME HIV/AIDS A SPECTRUM OF CONDITIONS CAUSED BY INFECTION WITH THE HUMAN IMMUNODEFICIENCY VIRUS

More information

Roche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics

Roche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics Media Release June 18, 2015 Roche to provide HIV diagnostic solutions to Global Fund Framework agreement with Global Fund strengthens access to HIV diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced

More information

A RESOLUTION IN SUPPORT OF AB 2640 ( GIPSON) PUBLIC HEALTH: HIV.

A RESOLUTION IN SUPPORT OF AB 2640 ( GIPSON) PUBLIC HEALTH: HIV. CITY COUNCIL MAY 16, 2016 CONSENT CALENDAR SUBJECT: INITIATED BY: A RESOLUTION IN SUPPORT OF AB 2640 ( GIPSON) PUBLIC HEALTH: HIV. MAYOR LAUREN MEISTER PREPARED BY: ( Hernan Molina, Governmental Affairs

More information

World Health Organization. A Sustainable Health Sector

World Health Organization. A Sustainable Health Sector World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL

More information

U.S. Response to the Global Threat of HIV/AIDS: Basic Facts

U.S. Response to the Global Threat of HIV/AIDS: Basic Facts U.S. Response to the Global Threat of HIV/AIDS: Basic Facts Alexandra E. Kendall Analyst in Global Health February 22, 2011 Congressional Research Service CRS Report for Congress Prepared for Members and

More information

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030 ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030 1. WE, the Heads of State and Government of the Association of Southeast

More information

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND... 8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION

More information

UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP

UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP WHY UNAIDS NEEDS YOUR SUPPORT Over the past 35 years, HIV has changed the course of history. The massive global impact of AIDS in terms

More information

Nursing Interventions

Nursing Interventions Chapter 16 H I Human Immunodeficiency V Virus A Acquired I Immuno D Deficiency S Syndrome Slide 1 Nursing Interventions Duty to treat Health care professionals may not pick and choose their patients Rehabilitation

More information

Children and AIDS Fourth Stocktaking Report 2009

Children and AIDS Fourth Stocktaking Report 2009 Children and AIDS Fourth Stocktaking Report 2009 The The Fourth Fourth Stocktaking Stocktaking Report, Report, produced produced by by UNICEF, UNICEF, in in partnership partnership with with UNAIDS, UNAIDS,

More information

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND... 5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES

More information

HIV/AIDS in the last 10 years

HIV/AIDS in the last 10 years S90 HIV/AIDS in the last 10 years Abdalla Sidahmed Osman 1 Introduction Now, 28 years after acquired immune deficiency syndrome (AIDS) was first recognised [1], it has become a global pandemic affecting

More information

HIV SCREENING WORKSHOP Exercise

HIV SCREENING WORKSHOP Exercise HIV SCREENING WORKSHOP Exercise INTRODUCTION: Since its first discovery in 1981, AIDS became a pandemic. Worldwide, actually over 30 million people are living with HIV (i.e., are infected by the human

More information

CRS Report for Congress

CRS Report for Congress CRS Report for Congress Received through the CRS Web Order Code RS21181 Updated May 2, 2003 HIV/AIDS International Programs: Appropriations, FY2002 - FY2004 Raymond W. Copson Specialist in International

More information

EDMA HIV-AIDS TEAM Fact Sheet November 2007

EDMA HIV-AIDS TEAM Fact Sheet November 2007 EDMA HIV-AIDS TEAM Fact Sheet November 2007 1. HIV Facts AIDS epidemic update UNAIDS Epidemic Update, November 2007 (1) 760,000 people to be living with HIV in Western and Central Europe in 2007. 31,000

More information

Women at Risk for HIV/AIDS. November 1, 2010 UMDNJ RWJMS Department of Obstetrics, Gynecology and Reproductive Health Charletta A.

Women at Risk for HIV/AIDS. November 1, 2010 UMDNJ RWJMS Department of Obstetrics, Gynecology and Reproductive Health Charletta A. Women at Risk for HIV/AIDS November 1, 2010 UMDNJ RWJMS Department of Obstetrics, Gynecology and Reproductive Health Charletta A. Ayers, MD, MPH Objectives What is the prevalence of HIV in the US? Who

More information

What Women Need to Know: The HIV Treatment Guidelines for Pregnant Women

What Women Need to Know: The HIV Treatment Guidelines for Pregnant Women : The HIV Treatment Guidelines for Pregnant Women : The HIV Treatment Guidelines for Pregnant Women What Women Need to Know: Prepared by Elaine Gross, RN, MS, CNS-C National Pediatric & Family HIV Resource

More information

Billing and Coding for HIV Services

Billing and Coding for HIV Services Billing and Coding for HIV Services Financial Disclosure This speaker does not have any financial relationships with commercial entities to disclose. This speaker will not discuss any off-label use or

More information

UNIÃO AFRICANA ABUJA CALL FOR ACCELERATED ACTION TOWARDS UNIVERSAL ACCESS TO HIV AND AIDS, TUBERCULOSIS AND MALARIA SERVICES IN AFRICA

UNIÃO AFRICANA ABUJA CALL FOR ACCELERATED ACTION TOWARDS UNIVERSAL ACCESS TO HIV AND AIDS, TUBERCULOSIS AND MALARIA SERVICES IN AFRICA AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA ABUJA CALL FOR ACCELERATED ACTION TOWARDS UNIVERSAL ACCESS TO HIV AND AIDS, TUBERCULOSIS AND MALARIA SERVICES IN AFRICA AFRICAN UNION UNION AFRICAINE UNIÃO

More information

PHSKC HIV Testing Survey: Knowledge, Attitudes and Practices

PHSKC HIV Testing Survey: Knowledge, Attitudes and Practices PHSKC HIV Testing Survey: Knowledge, Attitudes and Practices Page One This anonymous survey is intended to collect information about HIV testing attitudes and practices. Results will be used by Public

More information

NASDAQ: FHCO 2016 Annual Meeting

NASDAQ: FHCO 2016 Annual Meeting NASDAQ: FHCO 2016 Annual Meeting Q1 2016 At a Glance NASDAQ Core product FHCO FC2 Female Condom Gross margin ~66% Operating margin ~29% Total current assets $24 million no L/T debt Profitable Starting

More information

OF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan

OF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan Ratified President of the Republic of Armenia R. Kocharyan 1 April 2002 GOVERNMENT OF THE REPUBLIC OF ARMENIA DECREE 316 of 1 April 2002 Yerevan On ratification of the National Programme on HIV/AIDS Prevention

More information

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.

More information

Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment

Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment Joint WHO & UNAIDS Consultation with Pharmaceuticals and Stakeholders November 05 2012 Lara Stabinski, MD, MPH Medical

More information

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues EXECUTIVE BOARD EB44/ 44th session December 08 Provisional agenda item 5.8 Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues Ending tuberculosis Report

More information

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Highlight Disease: Malaria World s dominant protozoal disease. Four species of Plasmodium: P. falciparum (malignant), P. vivax (begnin),

More information

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014 Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations Emily McCloskey USCA October 3, 2014 About NASTAD NASTAD is an international non-profit association of U.S. state

More information

State of Alabama HIV Surveillance 2013 Annual Report Finalized

State of Alabama HIV Surveillance 2013 Annual Report Finalized State of Alabama HIV Surveillance 2013 Annual Report Finalized Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Isolated in 1983 by Luc Montagnier & Robert Gallo, separately. Genetic material is RNA Carries reverse transcriptase, an enzyme that makes DNA out of RNA in the host cell Cells

More information

HIV - Preventing New Infections: New Options, Readjusted Approaches

HIV - Preventing New Infections: New Options, Readjusted Approaches HIV - Preventing New Infections: New Options, Readjusted Approaches Ronald P. Hattis, MD, MPH Beyond AIDS Foundation Presented at Loma Linda University December 6, 2013 1 Thesis (Summary) As of 2013-14,

More information

Part I. Health-related Millennium Development Goals

Part I. Health-related Millennium Development Goals 11 1111111111111111111111111 111111111111111111111111111111 1111111111111111111111111 1111111111111111111111111111111 111111111111111111111111111111 1111111111111111111111111111111 213 Part I Health-related

More information

World Aids Day Luncheon- December 4th, 2009 Virginia Commonwealth University School of Medicine Gonzalo Bearman MD, MPH

World Aids Day Luncheon- December 4th, 2009 Virginia Commonwealth University School of Medicine Gonzalo Bearman MD, MPH World Aids Day Luncheon- December 4th, 2009 Virginia Commonwealth University School of Medicine Gonzalo Bearman MD, MPH Thank you for the invitation to speak today. I must first admit that, when sent this

More information

State of Alabama HIV Surveillance 2014 Annual Report

State of Alabama HIV Surveillance 2014 Annual Report State of Alabama HIV Surveillance 2014 Annual Report Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Richard P. Rogers, MS, MPH richard.rogers@adph.state.al.us

More information

MATERNAL HEALTH IN AFRICA

MATERNAL HEALTH IN AFRICA MATERNAL HEALTH IN AFRICA This Fact Sheet was prepared in January 2013 for the Summit of CARMMA (Campaign on Accelerated Reduction of Maternal, New Born and Child Mortality in Africa) in Addis Ababa Where

More information

CRS Report for Congress

CRS Report for Congress Order Code RS21181 Updated February 23, 2005 CRS Report for Congress Received through the CRS Web HIV/AIDS International Programs: Appropriations, FY2003-FY2006 Raymond W. Copson Specialist in International

More information

Economic and Social Council

Economic and Social Council United Nations E/CN.6/2010/L.6 Economic and Social Council Distr.: Limited 9 March 2010 Original: English ADOPTED 12 March 2010 ADVANCE UNEDITED VERSION Commission on the Status of Women Fifty-fourth session

More information

Understanding Epidemics Section 2: HIV/AIDS

Understanding Epidemics Section 2: HIV/AIDS Understanding Epidemics Section 2: HIV/AIDS Worksheet Fill out this worksheet as you work through the material on the website. 1. Give 4 reasons for the lack of accurate data on HIV/AIDS. 1 AIDS is not

More information

Antiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND

Antiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND KEY MESSAGES New WHO Recommendations: Antiretroviral therapy for adults and adolescents The World Health Organization (WHO) is revising its guidelines on antiretroviral therapy (ART) for adults and adolescents.

More information

Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa

Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa SUMMARY REPORT Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa January December 2012 Table of contents List of acronyms 2 Introduction 3 Summary

More information

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UNHLM ON TB KEY TARGETS FOR 2022 WE, HEADS OF STATE AND GOVERNMENT AND REPRESENTATIVES OF STATES AND GOVERNMENTS ASSEMBLED AT THE UNITED NATIONS

More information

REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES

REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES Information Brief: REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES Family Care International (FCI) developed this information brief as part of the Mobilising Advocates

More information

Uniting the world against AIDS

Uniting the world against AIDS Uniting the world against AIDS A letter from Peter Piot, Executive Director For over 27 years, our world has been living with HIV. And in just this short time, AIDS has become one of the make-or-break

More information

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead: CONTROLLED DOCUMENT Procedure for the management of patients with blood borne viruses CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled

More information

Translating Global Health Experiences Into International Policy: Experiments in Public Health, Politics, and Advocacy

Translating Global Health Experiences Into International Policy: Experiments in Public Health, Politics, and Advocacy Translating Global Health Experiences Into International Policy: Experiments in Public Health, Politics, and Advocacy Anand Reddi October 27, 2011 University of Colorado School of Medicine Email: anand.reddi@ucdenver.edu

More information

United Nations General Assembly June 8, 2011

United Nations General Assembly June 8, 2011 Remarks by Dr. Mathilde Krim United Nations General Assembly June 8, 2011 I am Mathilde Krim, the Founding Chairman of amfar, The Foundation for AIDS Research. This is a not-for-profit foundation based

More information

HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning. Bill Wade R.N June 21,2005.

HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning. Bill Wade R.N June 21,2005. HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning Bill Wade R.N June 21,2005. 1 Goals of this presentation Offer minimum content levels to enhance your learning needs around HIV/AIDS

More information

RESOLUTION RESPONDING TO AIDS: AN AUDIT OF AIDS DISCRIMINATION IN THE UNITED CHURCH OF CHRIST

RESOLUTION RESPONDING TO AIDS: AN AUDIT OF AIDS DISCRIMINATION IN THE UNITED CHURCH OF CHRIST RESOLUTION RESPONDING TO AIDS: AN AUDIT OF AIDS DISCRIMINATION IN THE UNITED CHURCH OF CHRIST [Adopted by the Seventeenth General Synod, United Church of Christ, Fort Worth, Texas, June 28-July 5, 1989.]

More information

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March

More information

Global Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group

Global Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group Global Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group 6 May 2015 Geneva Frederic Goyet, External Relations

More information

XIV INTERNATIONAL CONFERENCE PERSON LIVING WITH HIV IN FAMILY AND SOCIETY. Warsaw, Poland. 28 November 2007

XIV INTERNATIONAL CONFERENCE PERSON LIVING WITH HIV IN FAMILY AND SOCIETY. Warsaw, Poland. 28 November 2007 Speech [Note: e.g. Check against delivery] XIV INTERNATIONAL CONFERENCE PERSON LIVING WITH HIV IN FAMILY AND SOCIETY Warsaw, Poland 28 November 2007 Speech by Deborah Landey, Deputy Executive Director,

More information

THE EARLY TREATMENT FOR HIV ACT: MEDICAID COVERAGE FOR PEOPLE LIVING WITH HIV

THE EARLY TREATMENT FOR HIV ACT: MEDICAID COVERAGE FOR PEOPLE LIVING WITH HIV THE EARLY TREATMENT FOR HIV ACT: MEDICAID COVERAGE FOR PEOPLE LIVING WITH HIV INTRODUCTION The Early Treatment for HIV Act (ETHA) would allow states to extend Medicaid coverage to uninsured, non-disabled

More information

The Global Fund & UNICEF Partnership

The Global Fund & UNICEF Partnership The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and

More information

Monitoring the achievement of the health-related Millennium Development Goals

Monitoring the achievement of the health-related Millennium Development Goals SIXTY-SIXTH WORLD HEALTH ASSEMBLY A66/13 Provisional agenda item 14.1 14 May 2013 Monitoring the achievement of the health-related Millennium Development Goals Report by the Secretariat 1. In response

More information

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital HIV Lecture Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital End-2001 global estimates for children and adults People living with HIV/AIDS New HIV infections in

More information

Ensuring access to measures for the prevention of motherto-child transmission of HIV in prisons

Ensuring access to measures for the prevention of motherto-child transmission of HIV in prisons Resolution 26/2 Ensuring access to measures for the prevention of motherto-child transmission of HIV in prisons The Commission on Crime Prevention and Criminal Justice, Recalling all standards and norms

More information

PART IV. International Responses to the Risk of HIV in the Blood Supply

PART IV. International Responses to the Risk of HIV in the Blood Supply PART IV International Responses to the Risk of HIV in the Blood Supply Introduction Among the matters I was asked to review and report on are the structures and experiences of other countries, especially

More information

SIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item April Viral hepatitis. Report by the Secretariat

SIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item April Viral hepatitis. Report by the Secretariat SIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item 12.17 16 April 2009 Viral hepatitis Report by the Secretariat THE DISEASES AND BURDEN 1. The group of viruses that cause acute and/or chronic

More information

Syringe Exchange Programs December 2005

Syringe Exchange Programs December 2005 Syringe Exchange Programs December 2005 In 1997, a Report to Congress concluded that needle exchange programs can be an effective component of a comprehensive strategy to prevent HIV and other blood-borne

More information

HIV AND PEOPLE WHO INJECT DRUGS

HIV AND PEOPLE WHO INJECT DRUGS UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.

More information

Public health dimension of the world drug problem

Public health dimension of the world drug problem SEVENTIETH WORLD HEALTH ASSEMBLY A70/29 Provisional agenda item 15.3 27 March 2017 Public health dimension of the world drug problem Report by the Secretariat 1. The Executive Board at its 140th session

More information

Trends in U.S. HIV Diagnoses,

Trends in U.S. HIV Diagnoses, CDC FACT SHEET Trends in U.S. HIV Diagnoses, 2005-2014 More than three decades after the first cases of AIDS were diagnosed in the United States, HIV continues to pose a substantial threat to the health

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

Promoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia

Promoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia Promoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia The Global Health Initiative (GHI) is an integrated approach to global health

More information

HIV TESTING IN THE ERA OF TREATMENT SCALE UP

HIV TESTING IN THE ERA OF TREATMENT SCALE UP HIV TESTING IN THE ERA OF TREATMENT SCALE UP Kevin M. De Cock he ways in which global responses to HIV/AIDS have differed from responses to other infectious diseases have been extensively discussed in

More information

Dr. Tedros Adhanom, Together for a Healthier World

Dr. Tedros Adhanom, Together for a Healthier World Dr. Tedros Adhanom, Together for a Healthier World I envision a world where everyone can lead healthy and productive lives, regardless of who they are or where they live. Dr Tedros s vision if he is elected

More information

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a

More information

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a

More information

Introduction to HIV/AIDS

Introduction to HIV/AIDS HIV/AIDS Seminar 5 Welcome Back Introduction to HIV/AIDS History of HIV/AIDS It is now thought that HIV came from a similar virus found in chimpanzees - SIV. HIV probably entered North America around 1970

More information

UN Observance of International Women s Day Women and HIV/AIDS

UN Observance of International Women s Day Women and HIV/AIDS UN Observance of International Women s Day Women and HIV/AIDS The Pharmaceutical Industry Role in Addressing the Women and HIV/AIDS: Research, Access & Partnerships [prepared remarks] Linda M. Distlerath,

More information